WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • WJAHR: DECEMBER ISSUE PUBLISHED

    DECEMBER 2024 Issue has been successfully launched on DECEMBER 2024.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR December 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

TRANSFORMING THE MEDICAL LANDSCAPE: AN IN-DEPTH ANALYSIS OF THE ADVANCEMENTS IN PHARMACEUTICAL NANOMEDICINE

Sneha Kundu, Supratim Datta, Milan Kumar Maiti and *Partha Pratim Mahata

ABSTRACT

Nanotechnology is becoming more significant in the realms of medicine and medication delivery because traditional pharmaceutical agents and their antiquated formulations and delivery systems have serious limits. Since several nanotechnology applications have been created and a number of nanotechnology-based medications are currently available on the market, the impact of nanotechnology on healthcare is already being seen. The increasing number of drug candidates with poor solubility is reflected in the growing interest in drug nanoparticles and nano-cocrystals for research purposes; the primary use of these nanosystems is to increase solubility. Verifying these nanoparticles' lifetime functioning, the consistency of the formulation procedures, the produced systems' functional performance in a predetermined manner, and the systems' stability, it is vital to have a solid understanding of physic chemistry with the use of the appropriate analytical techniques. The bioavailability of a product can be affected by even minute variations in particle size, for instance, or size differences at the nanoscale. The Quality by design (QbD), which is defined by the FDA, is particularly useful for deciding on a stabilising agent and manufacturing process for pharmaceutical nanocrystals as well as determining Critical Quality Attributes (CQAs). The impact is amplified when dealing with the tiniest fractions of particles. Our goals were to assess the nanomedicines that have been given global market approval by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to briefly discuss the difficulties encountered during their development, and to consider potential future developments. In addition, a brief discussion will cover the significance of nanotechnology in the creation of pharmaceutical products, the ideal characteristics of nanocarriers, the causes of the failure of some nanomedicines, and the critical factors in the development of nanomedicines.

[Full Text Article] [Download Certificate]